003850.KS Overview

Company Profile

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

Related stocks

185750.KS

185750.KS • South Korea

65,900 KRW

647.98M USD 1Y -19.9%

195940.KQ

195940.KQ • South Korea

39,700 KRW

839.31M USD 1Y -13.3%

069620.KS

069620.KS • South Korea

108,500 KRW

931.65M USD 1Y -18.3%

3613.HK

3613.HK • Hong Kong SAR China

5.57 HKD

594.18M USD 1Y -37.8%

006280.KS

006280.KS • South Korea

GC Biopharma Corp.

129,400 KRW

1.1B USD 1Y -2.2%

FDC.BO

FDC.BO • India

330.1 INR

555.32M USD 1Y -27.9%

300485.SZ

300485.SZ • China

8.57 CNY

617.67M USD 1Y -24%

4559.T

4559.T • Japan

ZERIA PHARMACEUTICAL

1,925 JPY

536.21M USD 1Y -4.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Drug Manufacturers - Specialty & Generic

Website

https://www.boryung.co.kr

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

36.4% p.a.

Max Drawdown (5Y)

-56.4%

Sharpe Ratio (5Y)

-0.34

Beta Factor

0.34

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -65.3% in the extended horizon.